title: Bipolar transurethral enucleation and resection of the prostate versus bipolar resection of the prostate for prostates larger than 60gr: A retrospective study at a single academic tertiary care center.
abstract: OBJECTIVE
  To evaluate the efficacy and safety of bipolar transurethral enucleation and resection of the prostate (B-TUERP) versus bipolar transurethral resection of the prostate (B-TURP) in the treatment of prostates larger than 60g.
  
  
  METHODS
  Clinical data for 270 BPH patients who underwent B-TUERP and 204 patients who underwent B-TURP for BPH from May 2007 to May 2013 at our center were retrospectively analyzed. Outcome measures included operative time, decreased hemoglobin level, total prostate specific antigen (TPSA), International Prostate Symptom Score (IPSS), maximal urinary flow rate (Qmax), quality of life (QoL) score, post void residual urine volume (RUV), bladder irrigation duration, hospital stay, and the weight of resected prostatic tissue. Other measures included perioperative complications including transurethral resection syndrome (TURS), hyponatremia, blood transfusion, bleeding requiring surgery, postoperative acute urinary retention, urine incontinence and urinary sepsis. Patients in both groups were followed for two years.
  
  
  RESULTS
  Compared with the B-TURP group, the B-TUERP group had shorter operative time, postoperative bladder irrigation duration and hospital stay, a greater amount of resected prostatic tissue, less postoperative hemoglobin decrease, better postoperative IPSS and Qmax, as well as lower incidences of hyponatremia, urinary sepsis, blood transfusion requirement, urine incontinence and reoperation (P<0.05 for all).
  
  
  CONCLUSIONS
  B-TUERP is superior to B-TURP in the management of large volume BPH in terms of efficacy and safety, but this finding needs to be validated in further prospective, randomized, controlled studies.
authors: Department of Urology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
authors: Yong
authors: Y
authors: Wei
authors: Department of Urology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
authors: Ning
authors: N
authors: Xu
authors: Department of Urology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
authors: Shao-Hao
authors: SH
authors: Chen
authors: Department of Urology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
authors: Xiao-Dong
authors: XD
authors: Li
authors: Department of Urology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
authors: Qing-Shui
authors: QS
authors: Zheng
authors: Department of Urology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
authors: Yun-Zhi
authors: YZ
authors: Lin
authors: Department of Urology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
authors: Xue-Yi
authors: XY
authors: Xue
mesh_terms: D000368:Aged; D005500:Follow-Up Studies; D006801:Humans; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D061646:Operative Time; D011184:Postoperative Period; D011467:Prostate / Q000601:surgery*; D017430:Prostate-Specific Antigen / Q000097:blood; D011470:Prostatic Hyperplasia / Q000601:surgery*; D011788:Quality of Life; D012189:Retrospective Studies; D062606:Tertiary Care Centers; D007507:Therapeutic Irrigation; D020728:Transurethral Resection of Prostate / Q000009:adverse effects / Q000379:methods*; D016896:Treatment Outcome; D016055:Urinary Retention / Q000209:etiology; D014554:Urination
chemical_list: D017430:Prostate-Specific Antigen
keywords: Prostate; Prostatic Hyperplasia; Transurethral Resection of Prostate